NCT02415556View on ClinicalTrials.gov

Memory Aid by Intranasal Insulin in Diabetes (MemAID)

PHASE2CompletedINTERVENTIONAL

Enrollment

289

Participants

Timeline

Start Date

October 6, 2015

Primary Completion Date

May 31, 2020

Study Completion Date

May 31, 2020

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Regular Human Insulin

Regular human insulin 40 IU daily over 24 weeks

DRUG

Placebo

Intranasal sterile saline 40 IU daily over 24 weeks

Trial Locations (2)

02215

Brigham and Women's Hospital, Boston

Vera Novak, Boston

Sponsors

Collaborators (2)

Novo Nordisk A/S

All Listed Sponsors

collaborator

Novo Nordisk A/S

INDUSTRY

collaborator

Medtronic

INDUSTRY

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Beth Israel Deaconess Medical Center

OTHER